Clinical Trial Update: Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux® (HICARE) [Phase 4]

View source ↗

Summary

Phase 4 trial update examining skin changes during immuno-(chemo-) and radiotherapy with Erbitux in head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• ERBITUX (cetuximab)

Snippet

Sponsor: University of Heidelberg Medical Center | Conditions: Head and Neck Cancer | Phase 4 | Status: COMPLETED